A new trading day began on Monday, with Immunovant Inc (NASDAQ: IMVT) stock price up 5.11% from the previous day of trading, before settling in for the closing price of $14.68. IMVT’s price has ranged from $12.72 to $34.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -49.95%. With a float of $68.25 million, this company’s outstanding shares have now reached $147.20 million.
The firm has a total of 207 workers. Let’s measure their productivity. In terms of profitability, gross margin is 90.4%, operating margin of -27013.67%, and the pretax margin is -25478.07%.
Immunovant Inc (IMVT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunovant Inc is 59.82%, while institutional ownership is 49.43%. The most recent insider transaction that took place on Apr 09 ’25, was worth 364,941. In this transaction Chief Executive Officer of this company sold 28,094 shares at a rate of $12.99, taking the stock ownership to the 1,186,512 shares. Before that another transaction happened on Mar 07 ’25, when Company’s Director sold 8,000 for $19.60, making the entire transaction worth $156,769. This insider now owns 91,913 shares in total.
Immunovant Inc (IMVT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.74 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -49.95% per share during the next fiscal year.
Immunovant Inc (NASDAQ: IMVT) Trading Performance Indicators
Here are Immunovant Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.62, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of Immunovant Inc (IMVT)
Analysing the last 5-days average volume posted by the [Immunovant Inc, IMVT], we can find that recorded value of 2.61 million was better than the volume posted last year of 1.68 million. As of the previous 9 days, the stock’s Stochastic %D was 51.91%. Additionally, its Average True Range was 1.40.
During the past 100 days, Immunovant Inc’s (IMVT) raw stochastic average was set at 16.16%, which indicates a significant decrease from 43.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.76% in the past 14 days, which was higher than the 60.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.75, while its 200-day Moving Average is $25.80. Now, the first resistance to watch is $15.85. This is followed by the second major resistance level at $16.27. The third major resistance level sits at $16.90. If the price goes on to break the first support level at $14.80, it is likely to go to the next support level at $14.17. Should the price break the second support level, the third support level stands at $13.75.
Immunovant Inc (NASDAQ: IMVT) Key Stats
With a market capitalization of 2.62 billion, the company has a total of 169,861K Shares Outstanding. Currently, annual sales are 0 K while annual income is -259,340 K. The company’s previous quarter sales were 0 K while its latest quarter income was -111,120 K.
